Enedra Therapeutics

Private

LondonHealthcare & Life Scienceshttps://enedratx.com/

Last Round

VC Round

May 6, 2025

Company Overview

Enedra Therapeutics is a biotechnology company developing next-generation precision therapies for advanced, genetically heterogeneous cancers. The company leverages its proprietary AI-driven CASPAROV platform to discover novel drug targets and patient-specific biomarkers.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

AI drug discoverydrug target discoveryprecision oncologytechbioAI biotechdrug discovery platformcomputational biologybioinformaticsin silico drug discoverygenomics platformtumor heterogeneitytherapeutic resistancepreclinical biotechfirst-in-class drugsbiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Enedra Therapeutics Comparables

Compare Enedra Therapeutics with similar companies based on industry and business-model similarity.

Enedra Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Enedra Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	May 6, 2025

View all Funding Rounds

Enedra Therapeutics Investors

Notable investors and investment history

Enedra Therapeutics investors
Investor	Rounds
Deep Science Ventures	Seed, VC Round
o2h ventures	VC Round
Centre for Drug Design and Discovery	VC Round
Cancer Research Horizons	Seed, VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 6, 2025
Raised VC Round led by o2h ventures and Centre for Drug Design and Discovery.

View all signals

Enedra Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Enedra Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Enedra Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon

Year Founded2021

Last FundingMay 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.